Randomized, Double Blind, Placebo Controlled Comparison of Ritodrine and Hexoprenaline for Tocolysis Prior to External Cephalic Version at Term

Publisher Website
Google Scholar
Abstract
External cephalic versions in the study period were performed in a double blind design by 2 experienced practitioners. Sixty-three patients were allocated to treatment with either placebo, ritodrine or hexoprenaline. The main outcome measure studied was successful completion of external cephalic version. Hexoprenaline, but not ritodrine, was statistically more likely to be associated with successful version than placebo (p = 0.04 versus p = 0.22).

This publication has 7 references indexed in Scilit: